251 related articles for article (PubMed ID: 7163091)
1. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
Pakszys W; Ligezińska B; Szymański H
Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
[No Abstract] [Full Text] [Related]
2. [Diphenylhydantoin stimulation test in Wilson's disease].
Lössner J; Kühn HJ
Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):525-30. PubMed ID: 538130
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the need of ceruloplasmin and serum copper analyses in the diagnosis of Wilson's disease].
Nomoto S; Kanai M; Matsuda Y
Rinsho Byori; 1974 Oct; 22(10 Suppl):190. PubMed ID: 4475792
[No Abstract] [Full Text] [Related]
4. [Fluctuating blood copper concentrations].
Köbberling J
Dtsch Med Wochenschr; 1995 Mar; 120(13):461-2. PubMed ID: 7712938
[No Abstract] [Full Text] [Related]
5. [Detection of asymptomatic and preclinical forms of Wilson's disease by means of a test with 5,5-diphenylhydantoin (hydantoin Polfa)].
Pakszys W
Neurol Neurochir Pol; 1973; 7(2):237-41. PubMed ID: 4786333
[No Abstract] [Full Text] [Related]
6. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
Rosenberger K
Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
[No Abstract] [Full Text] [Related]
7. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
Wald I; Galewicz A; Górska D
Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
[No Abstract] [Full Text] [Related]
8. [On hepato-lenticular degeneration (Wilson's disease). I. Detection and early diagnosis].
Campanella G; Gillardi U; Germinario L
Acta Neurol (Napoli); 1971; 26(4):403-22. PubMed ID: 5132823
[No Abstract] [Full Text] [Related]
9. Value of an enzymatic assay for the determination of serum ceruloplasmin.
Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
[TBL] [Abstract][Full Text] [Related]
10. [Fatty liver hepatitis].
Seidler D
Dtsch Med Wochenschr; 1997 Jun; 122(24):802-3. PubMed ID: 9229566
[No Abstract] [Full Text] [Related]
11. [Diagnosis and differential diagnosis of hepatocerebral degeneration (Westphal-Strümpell-Wilson disease)].
Bachmann H; Biesold D; Eichner B; Günther K; Lössner J; Weise H; Willgerodt H
Z Arztl Fortbild (Jena); 1972 Jul; 66(13):670-4. PubMed ID: 4636967
[No Abstract] [Full Text] [Related]
12. [Pathobiochemistry of Wilson's disease].
Biesold D; Lössner J; Bachmann H; Zotter J
Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
[No Abstract] [Full Text] [Related]
13. [The value of biochemical determination of copper in clinical diagnosis of hepatolenticular degeneration].
Li NZ
Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):342-5. PubMed ID: 6414660
[No Abstract] [Full Text] [Related]
14. [Diagnosis of asymptomatic forms of hepatolenticular degeneration].
Kuncová Z; Dittrich J; Nevsímalová S; Marecek Z; Heyrovský A
Cesk Pediatr; 1971 Apr; 26(4):166-9. PubMed ID: 5553356
[No Abstract] [Full Text] [Related]
15. [The clinical characteristics and differential diagnosis of hyperkinetic forms of multiple sclerosis].
Chernigovskaia NV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):23-7. PubMed ID: 5425793
[No Abstract] [Full Text] [Related]
16. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
Kanai M; Nomoto S; Tsukagoshi H; Shindo M
Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
[No Abstract] [Full Text] [Related]
17. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
[No Abstract] [Full Text] [Related]
18. Factors influencing serum ceruloplasmin levels in normal individuals.
Cox DW
J Lab Clin Med; 1966 Dec; 68(6):893-904. PubMed ID: 5926186
[No Abstract] [Full Text] [Related]
19. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions.
Lyko J
Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192
[No Abstract] [Full Text] [Related]
20. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
Wald I; Galewicz A; Górska D
Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
